成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ANTI-HUMAN OPG

ANTI-HUMAN OPG Struktur
CAS-Nr.
Englisch Name:
ANTI-HUMAN OPG
Synonyma:
Anti-OPG;Anti-OCIF;Anti-HUMBTFB;ANTI-HUMAN OPG;ANTI-HUMAN TR1;Anti-TNFRSF11B;ANTI-HUMAN OCIF;ANTI-HUMAN TNFRSF11B;ANTI-HUMAN OSTEOPROTEGERIN;ANTI-OSTEOPROTEGERIN (HUMAN)
CBNumber:
CB7760424
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

ANTI-HUMAN OPG Eigenschaften

storage temp. 
−20°C
Aggregatzustand
lyophilized powder

Sicherheit

ANTI-HUMAN OPG Chemische Eigenschaften,Einsatz,Produktion Methoden

ANTI-HUMAN OPG Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


ANTI-HUMAN OPG Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Hao Biological Technology Co., Ltd. --
market@xlswkj.com CHINA 6793 58
Nanjing Sai Ruirui Biotechnology Co., Ltd. --
sales@shrbio.com CHINA 6871 58
BEIJING BIOSYNTHESIS BIOTECHNOLOGY CO., LTD. --
sales@bioss.com.cn CHINA 6717 58
Beijing Dakco is Biotechnology Co., Ltd. --
bj_info@dakewe.net CHINA 6348 58
Shanghai Yubo Biotechnology Co., Ltd. --
shybio@126.com CHINA 6967 58
Suzhou Ruinuode Biotechnology Co., Ltd. --
2090855807@qq.com CHINA 6063 58
Shanghai Beinuo Biotechnology Co., Ltd. --
beinuobio@163.com CHINA 6580 58
Beijing Bi Orange Blue Biotechnology Co., Ltd. --
bo49855987@163.com CHINA 6827 58
Shanghai Zeye Biotechnology Co., Ltd. --
shzeysw@163.com CHINA 6549 58
Riedel-de Haen AG --
United States 6773 87

  • Anti-TNFRSF11B
  • ANTI-OSTEOPROTEGERIN (HUMAN)
  • ANTI-OSTEOPROTEGERIN (OPG), HUMAN
  • ANTI-HUMAN TNF RECEPTOR LIKE PROTEIN-1
  • ANTI-HUMAN TR1
  • ANTI-HUMAN TNFRSF11B
  • ANTI-HUMAN OPG
  • ANTI-HUMAN OSTEOCLASTOGENESIS INHIBITORY FACTOR
  • ANTI-HUMAN OSTEOPROTEGERIN
  • ANTI-HUMAN OCIF
  • Anti-OPG
  • Anti-Osteoprotegerin antibody produced in goat
  • Anti-Basic transcription factor 3, like 1 pseudogene
  • Anti-BTF3L1 antibody produced in rabbit
  • Anti-HUMBTFB
  • Anti-OCIF
Copyright 2019 ? ChemicalBook. All rights reserved